Press release
Rising Cardiovascular Disease Prevalence Fuels Growth in Peripheral Vasodilator Drugs Market: An Emerging Driver Transforming The Peripheral Vasodilator Drugs Market Landscape
Peripheral Vasodilator Drugs
What Is the Projected Growth of the Peripheral Vasodilator Drugs Market?
The peripheral vasodilator drugs market has shown strong growth in recent years. It will rise from $6.27 billion in 2024 to $6.67 billion in 2025, with a CAGR of 6.3%. Factors driving this growth include the shift to less invasive surgery, the demand for minimally invasive heart devices, ongoing training for healthcare professionals, rising healthcare spending, and increasing patient preference for non-surgical or minimally invasive options.
The peripheral vasodilator drugs market is expected to see steady growth, reaching $8.44 billion by 2029 at a CAGR of 6.1%. This growth is driven by the aging population, increased heart health awareness, screening programs, favorable reimbursement policies for heart procedures, and timely regulatory approvals for new devices. Key trends include collaborations, real-world evidence, gene therapy, preventive interventions, and value-based healthcare.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16508
What Are the Different Peripheral Vasodilator Drugs Market Segments?
The peripheral vasodilator drugs market covered in this report is segmented -
1) By Drug Type: Calcium Channel Blockers, Direct-Acting Vasodilators, Alpha-Adrenergic Blockers, Potassium Channel Activators, Nitrates, Other Types
2) By Indication: Hypertension, Angina, Heart Failure, Other Indications
3) By Application: Hospital, Retail Pharmacies, Other Applications
Subsegments:
1) By Calcium Channel Blockers: Dihydropyridines, Non-Dihydropyridines
2) By Direct-Acting Vasodilators: Hydralazine, Minoxidil, Nitroprusside
3) By Alpha-Adrenergic Blockers: Prazosin, Doxazosin, Terazosin
4) By Potassium Channel Activators: Nicorandil, Diazoxide
5) By Nitrates: Nitroglycerin, Isosorbide Dinitrate, Isosorbide Mononitrate
6) By Other Types: Phosphodiesterase Inhibitors, Endothelin Receptor Antagonists
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16508&type=smp
What Are the Primary Drivers Shaping the Peripheral Vasodilator Drugs Market?
The increase in cardiovascular diseases is expected to fuel the growth of the peripheral vasodilator drug market. Cardiovascular diseases, often resulting from poor lifestyle choices, aging populations, and obesity, can lead to conditions like heart attacks and strokes. Peripheral vasodilators improve blood flow and alleviate symptoms associated with these conditions. According to the Australian Institute of Health and Welfare, deaths from coronary heart disease increased in 2022, driving the demand for peripheral vasodilator drugs.
Which Companies Are Leading in the Peripheral Vasodilator Drugs Market?
Major companies operating in the peripheral vasodilator drugs market are Pfizer Inc., Bayer AG, Sanofi S.A., Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Novartis AG, GSK plc, Takeda Pharmaceutical Company, Gilead Sciences Inc, Amgen Inc, Boehringer Ingelheim International GmbH, Merck & Co, Viatris Inc., Baxter, Teva Pharmaceutical Industries, Astellas Pharma, Daiichi Sankyo Company, Limited, Sun Pharmaceutical Industries, Mitsubishi Tanabe Pharma, Cipla Limited, Hikma Pharmaceuticals, Lupin Pharmaceuticals, Glenmark Pharmaceuticals Ltd, Torrent Pharmaceuticals, Ipca Laboratories, Alembic Pharmaceuticals
What Peripheral Vasodilator Drugs Market Trends Are Gaining Traction Across Different Segments?
Companies in the peripheral vasodilator drugs market are introducing fixed-dose combination therapies to treat hypertension more effectively. These triple-drug therapies cater to patients unresponsive to dual-drug regimens. For example, in August 2023, India-based Ajanta Pharma Limited introduced Met XL AMT, a fixed-dose combination of Telmisartan, Amlodipine, and Metoprolol, approved by the DCGI for treating uncontrolled hypertension in patients with stable coronary artery disease.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/peripheral-vasodilator-drugs-global-market-report
What Are the Top Revenue-Generating Geographies in the Peripheral Vasodilator Drugs Market?
North America was the largest region in the peripheral vasodilator drugs market in 2024. The regions covered in the peripheral vasodilator drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Peripheral Vasodilator Drugs Market?
2. What is the CAGR expected in the Peripheral Vasodilator Drugs Market?
3. What Are the Key Innovations Transforming the Peripheral Vasodilator Drugs Industry?
4. Which Region Is Leading the Peripheral Vasodilator Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Cardiovascular Disease Prevalence Fuels Growth in Peripheral Vasodilator Drugs Market: An Emerging Driver Transforming The Peripheral Vasodilator Drugs Market Landscape here
News-ID: 4044035 • Views: …
More Releases from The Business Research Company
Air Cargo And Freight Logistics Global Market Insights: Growth Drivers, Size & F …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Forecasted Market Growth Rate of the Air Cargo And Freight Logistics Industry?
The market size for air cargo and freight logistics has seen robust expansion in the past few years. The projection is that it will rise from $225.06 billion in 2024 to $240.65 billion in 2025, demonstrating…
Future of Two-wheeler Shock Absorber Market: Size, Share & Forecasts to 2029
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Projected Market Size Valuation of the Two-wheeler Shock Absorber Market by 2025?
The market size of the two-wheeler shock absorber has witnessed consistent growth over the recent years. It is projected to expand from $3.29 billion in 2024 to $3.39 billion in 2025, registering a compound annual growth…
Solar Powered Car Industry to Achieve $8.7 Billion Growth by 2029
Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Solar Powered Car Market Grow by 2025 in Terms of Size and Growth?
The market dimension of solar powered vehicles has undergone substantial growth in the past few years. It is projected to increase from $1.94 billion in 2024 to $2.58 billion in 2025, reflecting a compound annual growth…
Recreational Boating Market Growth to be Driven by Emerging Trends | $46.66 Bill …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Recreational Boating Industry?
The size of the recreational boating market has been on a steady rise over the past few years. This market is projected to escalate from $32.87 billion in 2024 to $34.94 billion in 2025, reflecting a compound annual growth rate…
More Releases for Vasodilator
Peripheral Vasodilator Drugs Market: Major Trends Reshaping the Future of the In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Peripheral Vasodilator Drugs Industry Market Size Be by 2025?
The market for peripheral vasodilator drugs has seen robust expansion in the recent past. The market will surge from $6.27 billion in 2024 to $6.67 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%.…
Rising Cardiovascular Disease Prevalence Fuels Growth in Peripheral Vasodilator …
The Peripheral Vasodilator Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Peripheral Vasodilator Drugs Market?
The peripheral vasodilator drugs market has shown strong growth in recent years. It will rise from $6.27 billion in 2024 to $6.67 billion…
Prominent Peripheral Vasodilator Drugs Market Trend for 2025: Innovation In Peri …
What industry-specific factors are fueling the growth of the peripheral vasodilator drugs market?
The increasing prevalence of cardiovascular diseases is expected to boost the growth of the peripheral vasodilator drug market. Cardiovascular diseases, which include conditions like heart attacks and strokes, are rising due to sedentary lifestyles, poor diets, and aging populations. Peripheral vasodilators improve blood flow, reduce blood pressure, and help manage conditions like peripheral arterial disease. The Australian Institute…
Prominent Peripheral Vasodilator Drugs Market Trend for 2025: Innovation In Peri …
What Are the Projected Growth and Market Size Trends for the Peripheral Vasodilator Drugs Market?
The market for peripheral vasodilator drugs has seen robust expansion in the past few years. The market, which was valued at $6.27 billion in 2024, is expected to reach $6.67 billion in 2025, growing at a compound annual growth rate (CAGR) of 6.3%. Factors contributing to this growth during the historic period include the adoption of…
Peripheral Vasodilator Drugs Market Report 2024-2033 | Size, Share, Trends, Grow …
The new report published by The Business Research Company, titled Peripheral Vasodilator Drugs Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
As per the report, the peripheral vasodilator drugs market size has grown strongly in recent years. It will grow from $5.92 billion…
Peripheral Vasodilator Drugs Market Key Players and Growth Analysis with Forecas …
Peripheral vasodilator drugs play a crucial role in managing peripheral vascular diseases by widening blood vessels, improving blood flow, and alleviating symptoms associated with conditions like peripheral artery disease (PAD) and Raynaud's disease. The market for these drugs is witnessing a steady surge owing to the growing burden of vascular disorders globally.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85487&utm_source=OPENPR%2FjayashriB&utm_campaign=OPENPR
Market Size and Growth:
The global Peripheral Vasodilator Drugs Market is projected to witness…
